We’re entering a time of uncertainty and anticipation. With the comment period for Stage 2 of Meaningful Use well underway, we await the Health and Human Service reaction and final rule. Meanwhile, the deadline for ICD-10 is likely to slip, for a yet unknown amount of time. Looming over these is the fate of healthcare reform itself, as the Supreme Court justices prepare their opinions.
Amid this uncertainty, work must go on and decisions have to be made. We continue to strive to provide insights on how to act now, and what key steps will likely need to be taken moving forward.
Harry Greenspun, M.D. Senior Advisor, Deloitte Center for Health Solutions